Rivaroxaban improves clinical outcomes in discharged COVID-19 patients Presented ByProf. Eduardo Ramacciotti, Santa Casa School of Medicine, Brasil ConferenceESC 2021 26 October, 2021 16:40
COVID-19: Thromboembolic risk reduction with therapeutic heparin dosing Presented ByProf. Alex Spyropoulos, Northwell Health, USA TrialPhase 3, HEP-COVID ConferenceESC 2021 26 October, 2021 16:34
